GRANTS 2019

PRGS

  • DR CHUA ANG LIM
  • EVALUATION OF FHV-KESAN: A MOLECULAR DIAGNOSTIC KIT PROTOTYPE FOR DETECTION OF FAMILIAL HYPERCHOLESTEROLAEMIA IN MALAYSIA 600-IRMI/PRGS 5/3 (002/2019)

  • Year of Grant Approval (Duration) : 1/1/2019 - 31/12/2020
  • PROF DR ANIS SAFURA RAMLI
  • DEVELOPMENT AND EVALUATION OF THE EMPOWER-SUSTAIN PROTOTYPE WEB-BASED AND COMPLEMENTARY MOBILE APPLICATIONS FOR SELF-MANAGEMENT OF CARDIOVASCULAR RISKS AMONG INDIVIDUALS WITH METABOLIC SYNDROME 600-IRMI/PRGS 5/3 (003/2019)

  • Year of Grant Approval (Duration) : 1/1/2019- 31/12/2020

FRGS

  • MANSHARAN KAUR A/P CHAINCHEL SINGH
  • IDENTIFYING ADIPOSE-SPECIFIC AMP-ACTIVATED PROTEIN KINASE ISOMERS VIA GENE EXPRESSIONS IN POST-MORTEM VISCERAL AND SUBCUTANEOUS TISSUES TARGETING OBESITY AND TYPE 2 DIABETES MELLITUS 600-IRMI/FRGS 5/3 (001/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2020
  • SHARANIZA BINTI AB RAHIM
  • MECHANISM OF THE ENHANCEMENT OF IMMUNE CELLS SENSITIZATION AND TRAFFICKING IN OSTEOSARCOMA BY SPIRONOLACTONE AND ROSIGLITAZONE TOWARDS ADOPTIVE IMMUNOTHERAPY IN MICE 600-IRMI/FRGS 5/3 (007/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • ROSFAIIZAH BINTI SIRAN
  • THE EFFECT OF PRENATAL BPA EXPOSURE ON THE EXPRESSION OF MICRORNA AND NMDA RECEPTOR SUBUNITS IN FETAL AND NEONATAL RAT HIPPOCAMPUS. 600-IRMI/FRGS 5/3 (029/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • RENU AGARWAL
  • MECHANISMS OF ACTION OF RESVERATROL AGAINST DEXAMETHASONE-INDUCED EXTRACELLULAR MATRIX REMODELING BY HUMAN TRABECULAR MESHWORK CELLS 600-IRMI/FRGS 5/3 (064/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • HAPIZAH BINTI MD NAWAWI
  • IN VITRO EFFECTS OF PCSK9 INHIBITORS ON BIOMARKERS OF ATHEROGENESIS IN HUMAN ENDOTHELIAL CELLS, ASSOCIATION BETWEEN PCSK9 WITH LP(A) AND THEIR CONTRIBUTION IN PATIENTS WITH PREMATURE 600-IRMI/FRGS 5/3 (067/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • NURUL ALIMAH BINTI ABDUL NASIR
  • MECHANISMS OF PROTECTIVE EFFECT OF TOCOTRIENOL-RICH FRACTION AGAINST DIABETIC RETINOPATHY IN RATS 600-IRMI/FRGS 5/3 (101/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • HEO CHONG CHIN
  • CORRELATION OF INSECT HORMONAL LEVELS IN MAGGOTS AND THE TIME OF DEATH: A NOVEL INSIGHT IN FORENSIC ENTOMOLOGY 600-IRMI/FRGS 5/3 (103/2019)

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • NUR BINTI ABDUL KARIM
  • IMPLICATIONS OF POLYMORPHISMS IN MTHFR, MS AND CBS GENES ON HOMOCYSTEINEMIA TREATMENT IN MALAYSIAN CARDIOVASCULAR 600-IRMI/FRGS 5/3 (318/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • WANG SEOK MUI
  • EXPRESSION, ANTIGENICITY AND CELLULAR RECEPTOR BINDING OF OUTER MEMBRANE PROTEIN A OF ORIENTIA TSUTSUGAMUSHI: A PRIMARY TARGET ANTIGEN OF THE HUMORAL IMMUNE RESPONSE 600-IRMI/FRGS 5/3 (339/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR MUDIANA BINTI MUHAMAD @ MOHD SAUFI
  • HUMAN NOROVIRUS REPLICATION IN A NOVEL 3D CULTURE SYSTEM VIA TOLL-LIKE RECEPTOR (TLRS) PATHWAY AND MODULATION BY COMMENSAL INTESTINAL BACTERIA 600-IRMI/FRGS 5/3 (354/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • PM DR DAMAYANTHI A/P DURAIRAJANAYAGAM
  • THE EFFECT OF EXERCISE ON LEPTIN-INDUCED CHANGES IN MALE GONADAL FUNCTION AND PI3K SIGNALLING PATHWAY IN THE TESTIS OF SPRAGUE-DAWLEY RATS. 600-IRMI/FRGS 5/3 (360/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NORA JULIANNA BINTI OSMAN
  • ELUCIDATION OF LONG NONCODING RNA, ZFAS1 ROLES IN MODULATING PTEN MUTANT AND PTEN WILD-TYPE GLIOBLASTOMA MULTIFORME CANCER CELL DEATH. 600-IRMI/FRGS 5/3 (361/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • PM DR SITI HAMIMAH BINTI SHEIKH ABDUL KADIR
  • THE IMPACT OF PERSISTENT ORGANIC POLLUTANT PERFLUOROOCTANE SULFONATE (PFOS) EXPOSURE ON THE EXPRESSION OF MICRORNAS AND DEVELOPMENT OF HYPERTROPHY IN ADULT HEART MODEL. 600-IRMI/FRGS 5/3 (362/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR EFFENDI BIN IBRAHIM
  • UNDERSTANDING HOW TOCOTRIENOL RICH FRACTION (TRF) MODULATES THE PROGRESSION OF HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ANIMAL MODEL. 600-IRMI/FRGS 5/3 (364/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NOOR ALICEZAH BINTI MOHD KASIM
  • IN-VIVO ATHEROPROTECTIVE MECHANISM OF AQUEOUS SAFFRON EXTRACT IN EXPERIMENTALLY INDUCED EARLY AND ESTABLISHED ATHEROSCLEROTIC RABBITS 600-IRMI/FRGS 5/3 (366/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NAVINDRA KUMARI A/P PALANISAMY
  • PROTEOGENOMIC ANALYSIS ON IMMUNOSTIMULATORY PROPERTIES OF EXTRACELLULAR SECRETORY PROTEINS OF STREPTOCOCCUS PNEUMONIAE 600-IRMI/FRGS 5/3 (384/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NOOR SHAFINA BINTI MOHD NOR
  • THE ROLE OF IN UTERO BISPHENOL A (BPA) EXPOSURE IN ENHANCING THE CONSEQUENCES OF TRANS FAT DIET ON GUT MICROBIOME AND SMALL INTESTINE DNA METHYLTRANSFERASES (DNMTS) EXPRESSION OF ANIMAL MODEL 600-IRMI/FRGS 5/3 (387/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NORHAFIZA BINTI RAZALI
  • MECHANISMS UNDERLYING THE EFFECT OF RESVERATROL ON EXTRACELLULAR MATRIX SECRETION BY DEXAMETHASONE-TREATED HUMAN TRABECULAR MESHWORK CELLS: FOCUS ON NON-CANONICAL TGF-β2- SIGNALLING 600-IRMI/FRGS 5/3 (413/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR AKMAL HISYAM BIN ARSHAD
  • EFFECT OF TOCOTRIENOL RICH FRACTION TOWARDS NUCLEAR FACTOR κB (NFκB) SIGNALING PATHWAY AND INFLAMMATORY MARKERS IN IN VITRO MODELS OF ENDOMETRIOSIS. 600-IRMI/FRGS 5/3 (456/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • MOHAMMAD JOHARI IBAHIM
  • INVESTIGATION OF THE ROLE OF CD8+ AND ITS CHEMOKINE IN RADIO-RESISTANT BREAST CANCER CELL TO GAMMA-RAY IRRADIATION USING THE 3D CULTURE SYSTEM 600-IRMI/FRGS 5/3 (456/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021

TRGS

REI

  • PROF DR HAPIZAH MD NAWAWI
  • MECHANISMS OF DRONE-ASSISTED TECHNOLOGY ON EFFICIENCY OF MASS DISASTER VICTIM IDENTIFICATION (DVI) 600-IRMI/TRGS 5/3 (001/2019)-2

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 31 Dec 2020
  • PROF DR NOR ASHIKIN MOHAMED NOOR KHAN
  • TOCOTRIENOL FOR THE IMPROVEMENT OF EMBRYONIC CRYOTOLERANCE: AN ULTRASTRUCTURAL ELUCIDATION 600-IRMI/REI 5/3 (002/2019)

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 31 Mac 2021

GIP

  • DR JAMAL HOUSSAINI
  • CHARACTERIZATION OF IMMUNOSTIMULATORY COMPOUNDS IN HELICOBACTER PYLORI FROM HUMAN AND ANIMAL TOWARDS UNDERSTANDING THE HOST PATHOGEN INTERACTION 600-IRMI 5/3/GIP (004/2019)

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 31 Mac 2020
  • DR THUHAIRAH HASRAH BINTI ABDUL RAHMAN
  • MECHANISM OF APOLIPOPROTEIN A1 AND APOLIPOPROTEIN E IN MODULATING SECERTIY OF FOUR DENGUE VIRUS SEROTYPES VIA SCAVENGER RECEPTOR B1 (SR- B1) IN VITRO 600-IRMI 5/3/GIP (025/2019)

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 31 Mac 2020
  • DR HASSANAIN ISSAM YEHYA YEHYA TALIB
  • FETERMINATION OF FRACTION OF STAPHYLOCOCCUS AUREUS WITH POSITIVE PVL GENE AMONG PATIENTS AND HEAL THCARE WORKERS IN SUNGAI BULOH HOSPITAL 600-IRMI 5/3/GIP (034/2019)

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 31 Mac 2020
  • PROF DR MUSALMAH BINTI MAZLAN
  • COMPARISON BIOAVAILABILITY AND TISSUE DISTRIBUTION OF NEW ENHANCED TOCOTRIENOL RICH FRACTION (ETRF) VERSUS TOCOTRIENEL RICH FRACTION (TRF) IN NORMAL MOUSE AND THEIR EFFICACY IN THE TREATMENT OF NON - ALCOHOLIC FATTY LIVER DISEASE (NAFLD) USING MOUSE MODEL 600-IRMI 5/3/GIP (063/2019)

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 31 Mac 2020

LESTARI

GOV

  • DR HASSANAIN ISSAM YEHYA YEHYA TALIB
  • PROTECTIVE AND ANTIMICROBIAL MECHANISMS OF ANTI-TETRASPANINS PEPTIDES AGAINST PSEUDOMONAS AERUGINOSA ADHERENCE TO HUMAN KERATINOCYTES 600-IRMI 5/3/LESTARI (012/2019)

  • Year of Grant Approval (Duration) : 1 Jul 2019 – 31 Jun 2021
  • DR ARJOANNA FARRA BINTI AZIZI
  • IDENTIFICATION OF G264V MUTATION ON AQP7 GENE AND CORRELATION OF PPARΑ ON MRNA EXPRESSIONS OF AQUAPORINS 7, 9 AND 10 IN OBESE SUBJECTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS 600-IRMI 5/3/LESTARI (013/2019)

  • Year of Grant Approval (Duration) : 1 Jul 2019 – 31 Jun 2021
  • DR SAFREEDA SF SALIM
  • IMPLICATIONS OF POLYMORPHISMS IN MTHFR, MS AND CBS GENES ON HOMOCYSTEINEMIA TREATMENT IN MALAYSIAN CARDIOVASCULAR PATIENTS 600-IRMI 5/3/LESTARI (018/2019)

  • Year of Grant Approval (Duration) : 1 Jul 2019 – 31 Jun 2021
  • ASSOC PROF DR FAZAH AKHTAR HANAPIAH
  • DATA SCIENCE PLATFIRM FOR SMART DIAGNOSIS OF UPPER LIMB SPASTICITY 100-IRMI/GOV 16/6/2 (0010/2019)

  • Year of Grant Approval (Duration) : 1 Jul 2019 – 1 Jul 2021

FRGS-RACER

  • DR ROQIAH FATMAWATI ABDUL KADIR
  • UNRAVELLING MECHANISMS OF NEUROPROTECTION BY RESVERATROL IN RATS WITH INTRACEREBRAL HAEMORRHAGE: NEW INSIGHT INTO THE ROLE OF ADENOSINE A1 RECEPTOR 600-IRMI/FRGS-RACER 5/3 (002/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR MAS IRFAN JAYA MAHAMOOTH
  • ITHE EFFECT OF PERICONCEPTION BISPHENOL-A EXPOSURE ON THE VIABILITY OF PREIMPLANTATION EMBRYOS 600-IRMI/FRGS-RACER 5/3 (088/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR LENY SUZANA SUDDIN
  • DEVELOPMENT OF AN IDEAL PATIENT SAFETY CULTURE MODEL (I-PSCM) FOR HEALTHCARE PROVIDER OF INPATIENT CARE 6600-IRMI/FRGS-RACER 5/3 (068/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR JULIANA YUSOF
  • EFFECTS OF PERFLUOROALKYL SUBSTANCES (PFASS) EXPOSURE ON MATERNAL, NEWBORN OUTCOME AND THEIRS POTENTIAL CARCINOGENIC IMPACT 600-IRMI/FRGS-RACER 5/3 (015/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR WAN ASMUNI WAN MOHD SAMAN
  • ELUCIDATING THE ROLE OF NOVEL TMPRSS6 GENE POLYMORPHISM IN THE MECHANISM OF IRON DEFICIENCY IN OBESITY 600-IRMI/FRGS-RACER 5/3 (016/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR ZATI SABRINA AHMAD ZUBAIDI
  • IDENTIFYING CAREGIVER BURDEN AMONG INFORMAL CAREGIVERS TO PALLIATIVE PATIENTS. 6600-IRMI/FRGS-RACER 5/3 (070/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR AHMAD BAKHTIAR MD RADZI
  • EMT-LENTIVIRAL FLUORESCENT REPORTER SYSTEM FOR THE IDENTIFICATION OF INHIBITORY AND REVERSAL ACTIVITIES OF RENAL FIBROSIS BY NOTCH INHIBITORS 600-IRMI/FRGS-RACER 5/3 (055/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR SITI NORBAHIYAH AWAD
  • DETERMINATION OF RICKETTSIAE GENETIC DIVERSITY IN ADULTS PRESENTING TO TELUK INTAN HOSPITAL THROUGH DNA SEQUENCING AND ITS IMPLICATIONS IN SEROLOGICAL DIAGNOSTICS 600-IRMI/FRGS-RACER 5/3 (056/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR HUZAIRI SANI
  • IMPACT OF THE MYSTEMI PRIMARY PCI PROGRAM ON IN-HOSPITAL DEATHS IN KUALA LUMPUR 6600-IRMI/FRGS-RACER 5/3 (067/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NORASHIKIN MOHD RANAI
  • UNDERSTANDING THE ROLE OF MICRORNA29A AND MICRORNA212 IN GUT TIGHT JUNCTION PROTEIN EXPRESSION OF RAT OFFSPRING EXPOSED TO BPA DURING IN-UTERO LIFE. 600-IRMI/FRGS-RACER 5/3 (008/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR KHAIRATUL NAINEY KAMARUDDIN
  • ESTABLISHING THE METABOLOMIC PROFILE IN PATIENTS WITH METABOLIC SYNDROME TAKING ORAL TRADITIONAL AND COMPLEMENTARY MEDICINE IN PRIMARY CARE 600-IRMI/FRGS-RACER 5/3 (069/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR WAN NOR I’ZZAH WAN MOHAMAD ZAIN
  • LAPATINIB-INDUCED CHANGES IN CACO-2 INTESTINAL MONOLAYER AND INTERVENTION WITH RECOMBINANT EPIDERMAL GROWTH FACTOR RECEPTOR (REGFR) 6600-IRMI/FRGS-RACER 5/3 (018/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NOR FARIDAH AHMAD ROSLAN
  • UNRAVELLING THE EFFECT OF MIRROR VISUAL FEEDBACK THERAPY IN MODULATING THE CORTICAL SIGNALS OF THE BRAIN THROUGH SURFACE ELECTROENCEPHALOGRAPHY (EEG) FOR STROKE RECOVERY 600-IRMI/FRGS-RACER 5/3 (071/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR AMIRAH ABDUL RAHMAN
  • ELUCIDATING THE EFFECT OF HYDROXYCHAVICOL IN COMBINATION WITH 5-FLUOROURACIL IN MODULATING THE PURINE METABOLISM OF COLORECTAL CANCER CELLS 600-IRMI/FRGS-RACER 5/3 (014/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NUR AMIRAH SHIBRAUMALISI
  • LELUCIDATING THE EFFECTS OF PERSISTENT ORGANIC POLLUTANTS (POP) PERCHLORINATED BIPHENYLS (PCB) EXPOSURE ON ATHEROSCLEROSIS (ATH) DEVELOPMENT AMONG ADULTS WITH METABOLIC SYNDROME (METS) AND IN VITRO MODEL 6600-IRMI/FRGS-RACER 5/3 (094/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR NATIARA MOHAMAD HASHIM
  • FUNDAMENTAL PROCESS ANALYSIS OF 3D- PRINTING TECHNOLOGY IN CUSTOMIZATION OF ASSISTIVE ADAPTIVE DEVICE PRESCRIPTION IN REHABILITATION MEDICINE 600-IRMI/FRGS-RACER 5/3 (106/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021
  • DR LEW SOOK WEIH
  • THE INVOLVEMENT OF FARNESOID-X RECEPTOR (FXR) AND ITS PATHWAY IN NAFLD MODEL TREATED WITH ENHANCED FORMULATION OF PALM TOCOTRIENOL RICH FRACTION 600-IRMI/FRGS-RACER 5/3 (109/2019)

  • Year of Grant Approval (Duration) : 1 Sep 2019 – 31 Aug 2021

PRGS

  • DR HASSANAIN ISSAM YEHYA YEHYA TALIB
  • EVALUATION OF PENTAPLEX PCR ASSAY: A MOLECULAR DIAGNOSTIC KIT PROTOTYPE FOR DETECTION OF HEMORRHAGIC BACTERIA FROM STOOL SAMPLES 600-RMC/PRGS 5/3 (016/2019)

  • Year of Grant Approval (Duration) : 1 Dec 2019 – 30 Nov 2021
  • PROF MADYA DR WANG SEOK MUI
  • DEVELOPMENT AND EVALUATION OF VIRAL-ENCEPH: A MOLECULAR DIAGNOSTIC KIT PROTOTYPE FOR DETECTION OF VIRAL ENCEPHALITIS 600-RMC/PRGS 5/3 (018/2019)

  • Year of Grant Approval (Duration) : 1 Dec 2019 – 30 Nov 2021

International/Private

  • JAMAL HOUSSAINI
  • EGEOGRAPHICAL MAPPING OF EMERGING TICK-BORNE PATHOGENS IN PENINSULAR MALAYSIA

  • Year of Grant Approval (Duration) : 1 Jan 2019 – 30 Dec 2021
  • HAZLYNA BINTI BAHARUDDIN
  • FACTORS ASSOCIATED WITH INTERMEDIATE AND HIGH PROBABILITY OF PULMONARY HYPERTENSION (PH) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS

  • Year of Grant Approval (Duration) : 1 Mac 2019 – 1 Feb 2020
  • HEO CHONG CHIN
  • ISOLATION AND IDENTIFICATION OF VARIEGATED SQUIRREL BORNAVIRUS 1 IN MALAYSIA

  • Year of Grant Approval (Duration) : 1 Jun 2019 – 31 May 2020
  • IGOR NIKOLAYEVICH IEZHITSA
  • BRAIN-DERIVED NEUROTROPHIC FACTOR ATTENUATES AMYLOID BETA 1-40 INDUCED VISUAL IMPAIREMENT IN SPRAGUE DAWLEY RATS

  • Year of Grant Approval (Duration) : 1 Apr 2019 – 30 Mac 2021
  • AMIRAH BINTI ABDUL RAHMAN
  • IDENTIFICATION OF THE ROLE IF EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2 (ENT2) IN MODULATING COLORECTAL CANCER CELL DEATH BY RNA INTERFERENCE.

  • Year of Grant Approval (Duration) : 8 May 2016 – 8 May 2021
  • MOHAMMED FAUZI BIN ABDUL RANI
  • CHARACTERISTIC AND DETERMINANTS OF TUBERCULOSIS TREATMENT SUCCESS AND MORTALITY AMONG WORKERS WITH TUBERCULOSIS

  • Year of Grant Approval (Duration) : 1 May 2019 – 31 May 2020
  • DIANA BINTI KATIMAN
  • IPOS-MAS: CULTURAL ADAPTATION AND VALIDATION O THE INTEGRATED PALLIATIVE CARE OUTCOME SCALE (IPOS) FOR USE AMONG PALLIATIVE CARE IN MALAYSIA

  • Year of Grant Approval (Duration) : 1 Mac 2019 – 28 Feb 2021
  • SAZZLI SHAHLAN BIN KASIM
  • A PHASE 3, MULTICENTRE, DOUBLE-BLIND, RANDOMIED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CSL112 IN SUBJECTS WITH ACUTE CORONARY SYNDROME (AEGIS II)

  • Year of Grant Approval (Duration) : 1 May 2019 – 30 May 2023
  • MUHAMMAD IQBAL BIN ABDUL HAFIDZ
  • A MULTICENTER INTERNATIONAL RANDOMISED PARALLEL GROUP DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIAL OF EMPAGLIFLOZIN ONCE DAILY TO ASSESS CARDIO-RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  • Year of Grant Approval (Duration) : 1 Oct 2019 – 30 Sept 2024
  • MOHAMAD IQHBAL BIN KUNJI MOHAMAD
  • ASSESSMENT OF LOW RISK CHEST PAIN IN EMERGENCY DEPARTMENT-AITRIAGE VS HEART SCORE

  • Year of Grant Approval (Duration) : 1 Jun 2019 – 30 Jun 2020
  • HEO CHONG CHIN
  • NECROBIOME COMMUNITY STRUCTURE AND SOIL CHEMISTRY PROFILES ASSOCIATED WITH PENGUIN CARCASSES AND ITS CORRELATION WITH BONE DENSITY UNDER ANTARCTICA CLIMATE

  • Year of Grant Approval (Duration) : 1 JUn 2019 – 31 May 2022